WOOJUNG BIO バランスシートの健全性
財務の健全性 基準チェック /06
WOOJUNG BIO has a total shareholder equity of ₩25.5B and total debt of ₩48.4B, which brings its debt-to-equity ratio to 190.1%. Its total assets and total liabilities are ₩91.2B and ₩65.7B respectively.
主要情報
190.1%
負債資本比率
₩48.41b
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | ₩2.93b |
| エクイティ | ₩25.47b |
| 負債合計 | ₩65.74b |
| 総資産 | ₩91.21b |
財務の健全性に関する最新情報
Recent updates
Why Investors Shouldn't Be Surprised By WOOJUNG BIO, Inc.'s (KOSDAQ:215380) 30% Share Price Plunge
Oct 14
WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Shares Bounce 43% But Its Business Still Trails The Industry
Aug 16Revenues Working Against WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Share Price Following 26% Dive
Jun 14Is WOOJUNG BIO (KOSDAQ:215380) Weighed On By Its Debt Load?
May 23財務状況分析
短期負債: A215380's short term assets (₩14.7B) do not cover its short term liabilities (₩35.8B).
長期負債: A215380's short term assets (₩14.7B) do not cover its long term liabilities (₩30.0B).
デット・ツー・エクイティの歴史と分析
負債レベル: A215380's net debt to equity ratio (178.6%) is considered high.
負債の削減: A215380's debt to equity ratio has increased from 47% to 190.1% over the past 5 years.
債務返済能力: A215380's debt is not well covered by operating cash flow (3.2%).
インタレストカバレッジ: Insufficient data to determine if A215380's interest payments on its debt are well covered by EBIT.